Use access key #2 to skip to page content.
$26.23 0.02 (0.08%)
10/10/2008 4:04 PM

Merck & Co., Inc. (MRK)

CAPS Rating:
****

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

View Ticker Page (MRK)

Results 31 - 40 of 317 :   12345Next »

Recs

1

Avatar oggerg (70.90) Submitted: 2/22/07 5:54 PM : Outperform Start Price: $40.70 MRK Score: 3.72

Ethical - handles Vioxx crisis. Best place to work for the last 2 decades. Big market share. Friendly to employees and shareholders. Big 4% dividend. Brands: Zocor, for atherosclerosis, Cozaar, Hyzaar, and Vasotec for hypertension, Fosamax for osteop...

Report this Post Replies: 2 | Reply | Permalink

Recs

1

Avatar cosmo2066 (75.78) Submitted: 6/06/07 11:40 AM : Outperform Start Price: $48.65 MRK Score: -4.22

Merck & Co., Inc. engages in the discovery, development, manufacture, and marketing of various products for human and animal health. MRK suffered from Vioxx litigation, but has largely recovered. This dividend machine is driven by a few key performer...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar skidownhill (< 20) Submitted: 6/20/07 9:46 PM : Outperform Start Price: $46.96 MRK Score: -2.72

Strong, determined leadership from a long time insider. Well thought out and committed plan to recover lost revenue due to patent expiration and Vioxx lawsuits. Senior managment driving change at all levels.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar demoledor (29.02) Submitted: 3/24/08 6:09 PM : Outperform Start Price: $43.44 MRK Score: -5.24

What a chance to buy a leader like this for a 25% discount... Go look at the historical prices


Oh, and for purists, it has closed the gap it left in April 2007 so it can now go up unchallenged, back to where it belongs.


And al...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar jep2224 (47.00) Submitted: 3/24/08 12:15 PM : Outperform Start Price: $43.53 MRK Score: -5.17

A leading pharmaceutical growth company with multiple products in research or in the pipeline in human testing trial stage or near approval by FDA. Only one executive Ms. Wendy Yarno sold large shares of her position at $52 (52 week high $55),much hi...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar johnjosiah (< 20) Submitted: 2/09/07 10:10 AM : Outperform Start Price: $41.65 MRK Score: 2.03

First provider of the hot topic genital warts vaccine. Stands to make alot of money.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Superunderdoggie (61.05) Submitted: 9/30/08 12:59 PM : Outperform Start Price: $31.00 MRK Score: 7.04







These guys should come back already...after years of getting hammered its time they do something right and recapture their former glory. I think by now perhaps their arrogance has been tempered and maybe they are ready to g...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar Bigbruizer (85.25) Submitted: 9/19/06 5:20 AM : Outperform Start Price: $38.67 MRK Score: 0.85

Undervalued still even after rising over 40. Pays a good dividend and has good pipeline. Concern over law suits is over done

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar ridumac2 (< 20) Submitted: 9/26/08 4:30 PM : Outperform Start Price: $31.89 MRK Score: 7.99

How can you pass up these dividend rates?

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar StudioBytes (< 20) Submitted: 9/05/07 9:11 AM : Outperform Start Price: $47.79 MRK Score: -4.83

took some hits and lost some share, they are posting some great replacement pitches for some new drugs that if they hit should push them higher. I would say keep buying while its still reasonable.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners